Figure 1. Terminating the expression of SV40T antigen with doxycycline induction in reversibly immortalized NHEK resulted in reduced mitotic ability. (A) Immunofluorescent staining of Ki67, SV40-T, F-actin and DAPI of NHEKs and reversibly immortalized keratinocytes with PBS or Dox treatment. Scale bar = 20 μm. (B, C) Statistical analysis for (A) (****P < 0.0001). (D) EdU staining analysis of NHEKs and reversibly immortalized keratinocytes with PBS or Dox treatment. Scale bar = 20 μm (****P < 0.0001). (E) Statistical analysis for (D) (****P < 0.0001, ns indicates not significant). All data are represented as mean +/- SEM. (F) CCK-8 assay for NHEKs and reversibly immortalized keratinocytes treated with either doxycycline (Dox) or PBS control (****P < 0.0001). (G) Clone formation assay for NHEKs and reversibly immortalized keratinocytes treated with either Dox or PBS control. (H) Statistical analysis for (G) (****P < 0.0001, ns indicates not significant).